The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
case-study
Synthesizing Success: Syner-G’s Strategic Solutions for Elevating a Biotech Innovator
Read More
case-study
Regulatory Expectations for Sterile Filtration Process Control
Read More
case-study
Strategic CMC Development Partnership Enabling Timely Approval and Launch of a Breakthrough Product
Read More
case-study
Partnership with a Canadian Pharma Organization resulted in savings in effort and material cost for time-critical clinical program
Read More
Let's move from science to success.
Let’s Talk